Literature summary for 2.8.2.5 extracted from

Oliveira-Ferrer, L.; Hessling, A.; Trillsch, F.; Mahner, S.; Milde-Langosch, K.
Prognostic impact of chondroitin-4-sulfotransferase CHST11 in ovarian cancer (2015), Tumour Biol., 36, 9023-9030.

Search for more literature for 2.8.2.5

Application

Application	Comment	Organism
medicine	the enzyme is an independent unfavorable prognostic factor for ovarian cancer progression	Homo sapiens

Natural Substrates/ Products (Substrates)

Natural Substrates	Organism	Comment (Nat. Sub.)	Natural Products	Comment (Nat. Pro.)	Rev.	Reac.
3'-phosphoadenylyl sulfate + chondroitin	Homo sapiens	-	adenosine 3',5'-bisphosphate + chondroitin 4'-sulfate	-	?

Organism

Organism	UniProt	Comment	Textmining
Homo sapiens	Q9NPF2	-	-

Source Tissue

Source Tissue	Comment	Organism	Textmining
ovarian carcinoma cell	-	Homo sapiens	-

Substrates and Products (Substrate)

Substrates	Comment Substrates	Organism	Products	Comment (Products)	Rev.	Reac.
3'-phosphoadenylyl sulfate + chondroitin	-	Homo sapiens	adenosine 3',5'-bisphosphate + chondroitin 4'-sulfate	-	?

Synonyms

Synonyms	Comment	Organism
chondroitin-4-sulfotransferase	-	Homo sapiens
CHST11	-	Homo sapiens

Expression

Organism	Comment	Expression
Homo sapiens	a significantly higher mRNA expression of CHST11 is measured in ovarian cancer samples in comparison to non-malignant ones	up

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)